Reassessing the role of histaminergic tuberomammillary neurons in arousal control

  1. Patrick M. Fuller1
  1. 1Department of Neurology, Beth Israel Deaconess Medical Center and Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts 02215
  2. 2Academic Research and Industrial Collaboration Management Office of Kyushu University, 3-8-34 Momochihama, Sawara-ku, Fukuoka, 814-0001, Japan
  3. 3Department of Neurobiology, Brudnick Neuropsychiatric Research Institute, NeuroNexus Institute, Graduate Program in Neuroscience - Graduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, MA.
  1. Correspondence should be addressed to Dr. Patrick M. Fuller, Beth Israel Deaconess Medical Center, Department of Neurology, E/CLS 707, 3 Blackfan Circle, Boston, MA 02115. pfuller{at}bidmc.harvard.edu
  1. Author contributions: A.V., T.M., C.A., T.E.S., C.B.S., E.A., and P.M.F. designed research; A.V., T.M., and R.D.L. performed research; A.V., T.M., and R.D.L. analyzed data; A.V., T.M., and P.M.F. wrote the first draft of the paper; A.V., R.D.L., C.A., T.E.S., C.B.S., E.A., and P.M.F. edited the paper; A.V. and P.M.F. wrote the paper.

Abstract

The histaminergic neurons of the tuberomammillary nucleus (TMNHDC) of the posterior hypothalamus have long been implicated in promoting arousal. More recently, a role for GABAergic signalling by the TMNHDC neurons in arousal control has been proposed. Here, we investigated the effects of selective chronic disruption of GABA synthesis (via genetic deletion of the GABA synthesis enzyme, glutamic acid decarboxylase 67) or GABAergic transmission (via genetic deletion of the vesicular GABA transport (VGAT)) in the TMNHDC neurons on sleep-wake in male mice. We also examined the effects of acute chemogenetic activation and optogenetic inhibition of TMNHDC neurons upon arousal in male mice. Unexpectedly, we found that neither disruption of GABA synthesis nor GABAergic transmission altered hourly sleep-wake quantities, perhaps because very few TMNHDC neurons co-expressed VGAT. Acute chemogenetic activation of TMNHDC neurons did not increase arousal levels above baseline but did enhance vigilance when the mice were exposed to a behavioral cage change challenge. Similarly, acute optogenetic inhibition had little effect upon baseline levels of arousal. In conclusion, we could not identify a role for GABA release by TMNHDC neurons in arousal control. Further, if TMNHDC neurons do release GABA, the mechanism by which they do so remains unclear. Our findings support the view that TMNHDC neurons may be important for enhancing arousal under certain conditions, such as exposure to a novel environment but play only a minor role in behavioral and EEG arousal under baseline conditions.

SIGNIFICANCE STATEMENT

The histaminergic neurons of the tuberomammillary nucleus of the hypothalamus (TMNHDC) have long been thought to promote arousal. Additionally, TMNHDC neurons may counter-regulate the wake-promoting effects of histamine through co-release of the inhibitory neurotransmitter, GABA. Here, we show that impairing GABA signalling from TMNHDC neurons does not impact sleep-wake amounts and that few TMNHDC neurons contain the vesicular GABA transporter, which is required to release GABA. We further show that acute activation or inhibition of TMNHDC neurons has limited effects upon baseline arousal levels and that activation enhances vigilance during a behavioural challenge. Counter to general belief, our findings support the view that TMNHDC neurons are neither necessary nor sufficient for the initiation and maintenance of arousal under baseline conditions.

Footnotes

  • The authors declare no competing financial interests.

  • Lauren T. Sohn, Sathyajit Bandaru, Mihoko Yamamoto, Sara Hyde, Shoshi Freeman, Quan Ha, Minh Ha, Sarah Keating, Miriam DeBruyne, Rebecca Y. Broadhurst, Tilar Martin. We are especically grateful to Dr. Jeffrey Zigman for providing the HDC-cre mice.

  • SRSF CDA #016-JP-17 and NARSAD Young Investigator's Grant 20964 to A.V.., G. Harold and Leila Y. Mathers Foundation HL095491 to C.B.S and NS073613, NS092652 and NS103161 to P.M.F.

  • Received May 7, 2019.
  • Revision received September 16, 2019.
  • Accepted September 19, 2019.